胃癌伴腹膜转移的不同免疫抑制肿瘤微环境。

IF 3.8 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hongsik Kim, Minsuk Kwon, Sun Kyung Lee, Seung-Myoung Son, Ok-Jun Lee, Soon Man Yoon, Hee Kyung Kim, Yaewon Yang, Ki Hyeong Lee, Hye Sook Han
{"title":"胃癌伴腹膜转移的不同免疫抑制肿瘤微环境。","authors":"Hongsik Kim, Minsuk Kwon, Sun Kyung Lee, Seung-Myoung Son, Ok-Jun Lee, Soon Man Yoon, Hee Kyung Kim, Yaewon Yang, Ki Hyeong Lee, Hye Sook Han","doi":"10.5230/jgc.2025.25.e46","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Immunotherapy combined with chemotherapy is the standard palliative treatment for gastric cancer. However, peritoneal metastases are often resistant to immunotherapy, underscoring the need to better understand the tumor immune microenvironment (TIME). In this study, we aimed to comprehensively analyze the TIME in peritoneal metastases of gastric cancer.</p><p><strong>Materials and methods: </strong>Paired single-cell suspensions from malignant ascites and peripheral blood mononuclear cells (PBMCs) were obtained from 27 patients with gastric cancer for multicolor fluorescence-activated cell sorting (FACS) analysis. Cell-free fluids from malignant ascites and plasma of 15 patients with gastric cancer, along with benign ascites from 15 patients with liver cirrhosis, were analyzed using multiplex enzyme-linked immunosorbent assay (ELISA). Paired samples of primary gastric tumors and metastatic peritoneal tumors from 12 patients were evaluated using multiplex immunohistochemistry (IHC).</p><p><strong>Results: </strong>FACS analysis revealed that T cells in malignant ascites expressed higher levels of immune checkpoint receptors (programmed death-1, T-cell immunoglobulin and mucin-domain containing-3, T-cell immunoglobulin and ITIM domain, lymphocyte activation gene-3, and cytotoxic T-lymphocyte antigen 4), and that CD8⁺ T cells exhibited terminal exhaustion (Eomes<sup>high</sup>T-bet<sup>low</sup>). Multiplex ELISA showed that soluble immunosuppressive factors (matrix metalloproteinase [MMP]-1, MMP-2, MMP-7, transforming growth factor-beta 1, hepatocyte growth factor, E-cadherin, vascular endothelial growth factor, and angiopoietin-2) were elevated in malignant ascites. Multiplex IHC showed lower CD4⁺ and CD8⁺ T cell densities in metastatic peritoneal tumors, which predominantly exhibited immunosuppressive TIME subtypes (immune-desert and intrinsic induction).</p><p><strong>Conclusions: </strong>Our results revealed distinct peritoneal immunosuppressive TIMEs in patients with gastric cancer with peritoneal metastasis.</p>","PeriodicalId":56072,"journal":{"name":"Journal of Gastric Cancer","volume":"25 4","pages":"605-620"},"PeriodicalIF":3.8000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536193/pdf/","citationCount":"0","resultStr":"{\"title\":\"Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis.\",\"authors\":\"Hongsik Kim, Minsuk Kwon, Sun Kyung Lee, Seung-Myoung Son, Ok-Jun Lee, Soon Man Yoon, Hee Kyung Kim, Yaewon Yang, Ki Hyeong Lee, Hye Sook Han\",\"doi\":\"10.5230/jgc.2025.25.e46\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Immunotherapy combined with chemotherapy is the standard palliative treatment for gastric cancer. However, peritoneal metastases are often resistant to immunotherapy, underscoring the need to better understand the tumor immune microenvironment (TIME). In this study, we aimed to comprehensively analyze the TIME in peritoneal metastases of gastric cancer.</p><p><strong>Materials and methods: </strong>Paired single-cell suspensions from malignant ascites and peripheral blood mononuclear cells (PBMCs) were obtained from 27 patients with gastric cancer for multicolor fluorescence-activated cell sorting (FACS) analysis. Cell-free fluids from malignant ascites and plasma of 15 patients with gastric cancer, along with benign ascites from 15 patients with liver cirrhosis, were analyzed using multiplex enzyme-linked immunosorbent assay (ELISA). Paired samples of primary gastric tumors and metastatic peritoneal tumors from 12 patients were evaluated using multiplex immunohistochemistry (IHC).</p><p><strong>Results: </strong>FACS analysis revealed that T cells in malignant ascites expressed higher levels of immune checkpoint receptors (programmed death-1, T-cell immunoglobulin and mucin-domain containing-3, T-cell immunoglobulin and ITIM domain, lymphocyte activation gene-3, and cytotoxic T-lymphocyte antigen 4), and that CD8⁺ T cells exhibited terminal exhaustion (Eomes<sup>high</sup>T-bet<sup>low</sup>). Multiplex ELISA showed that soluble immunosuppressive factors (matrix metalloproteinase [MMP]-1, MMP-2, MMP-7, transforming growth factor-beta 1, hepatocyte growth factor, E-cadherin, vascular endothelial growth factor, and angiopoietin-2) were elevated in malignant ascites. Multiplex IHC showed lower CD4⁺ and CD8⁺ T cell densities in metastatic peritoneal tumors, which predominantly exhibited immunosuppressive TIME subtypes (immune-desert and intrinsic induction).</p><p><strong>Conclusions: </strong>Our results revealed distinct peritoneal immunosuppressive TIMEs in patients with gastric cancer with peritoneal metastasis.</p>\",\"PeriodicalId\":56072,\"journal\":{\"name\":\"Journal of Gastric Cancer\",\"volume\":\"25 4\",\"pages\":\"605-620\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536193/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Gastric Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5230/jgc.2025.25.e46\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastric Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5230/jgc.2025.25.e46","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:免疫联合化疗是胃癌的标准姑息治疗方法。然而,腹膜转移瘤通常对免疫治疗有耐药性,这强调了更好地了解肿瘤免疫微环境(TIME)的必要性。在本研究中,我们旨在综合分析胃癌腹膜转移的TIME。材料与方法:选取27例胃癌患者的恶性腹水单细胞悬液和外周血单核细胞(PBMCs)进行多色荧光活化细胞分选(FACS)分析。采用多重酶联免疫吸附试验(ELISA)对15例胃癌患者恶性腹水、血浆及15例肝硬化患者良性腹水的无细胞液进行了分析。采用多重免疫组化(IHC)对12例原发性胃肿瘤和转移性腹膜肿瘤的配对样本进行评估。结果:FACS分析显示,恶性腹水中的T细胞表达更高水平的免疫检查点受体(程序性死亡-1、T细胞免疫球蛋白和黏液结构域-3、T细胞免疫球蛋白和ITIM结构域、淋巴细胞活化基因-3和细胞毒性T淋巴细胞抗原4),CD8 + T细胞表现出终末衰竭(EomeshighT-betlow)。多重ELISA结果显示,可溶性免疫抑制因子(基质金属蛋白酶[MMP]-1、MMP-2、MMP-7、转化生长因子- β 1、肝细胞生长因子、e -钙粘蛋白、血管内皮生长因子、血管生成素-2)在恶性腹水中升高。多重IHC显示,转移性腹膜肿瘤中CD4 +和CD8 + T细胞密度较低,主要表现为免疫抑制型TIME亚型(免疫荒漠型和内在诱导型)。结论:我们的研究结果显示胃癌伴腹膜转移患者的腹膜免疫抑制时间明显不同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis.

Purpose: Immunotherapy combined with chemotherapy is the standard palliative treatment for gastric cancer. However, peritoneal metastases are often resistant to immunotherapy, underscoring the need to better understand the tumor immune microenvironment (TIME). In this study, we aimed to comprehensively analyze the TIME in peritoneal metastases of gastric cancer.

Materials and methods: Paired single-cell suspensions from malignant ascites and peripheral blood mononuclear cells (PBMCs) were obtained from 27 patients with gastric cancer for multicolor fluorescence-activated cell sorting (FACS) analysis. Cell-free fluids from malignant ascites and plasma of 15 patients with gastric cancer, along with benign ascites from 15 patients with liver cirrhosis, were analyzed using multiplex enzyme-linked immunosorbent assay (ELISA). Paired samples of primary gastric tumors and metastatic peritoneal tumors from 12 patients were evaluated using multiplex immunohistochemistry (IHC).

Results: FACS analysis revealed that T cells in malignant ascites expressed higher levels of immune checkpoint receptors (programmed death-1, T-cell immunoglobulin and mucin-domain containing-3, T-cell immunoglobulin and ITIM domain, lymphocyte activation gene-3, and cytotoxic T-lymphocyte antigen 4), and that CD8⁺ T cells exhibited terminal exhaustion (EomeshighT-betlow). Multiplex ELISA showed that soluble immunosuppressive factors (matrix metalloproteinase [MMP]-1, MMP-2, MMP-7, transforming growth factor-beta 1, hepatocyte growth factor, E-cadherin, vascular endothelial growth factor, and angiopoietin-2) were elevated in malignant ascites. Multiplex IHC showed lower CD4⁺ and CD8⁺ T cell densities in metastatic peritoneal tumors, which predominantly exhibited immunosuppressive TIME subtypes (immune-desert and intrinsic induction).

Conclusions: Our results revealed distinct peritoneal immunosuppressive TIMEs in patients with gastric cancer with peritoneal metastasis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Gastric Cancer
Journal of Gastric Cancer Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
4.30
自引率
12.00%
发文量
36
期刊介绍: The Journal of Gastric Cancer (J Gastric Cancer) is an international peer-reviewed journal. Each issue carries high quality clinical and translational researches on gastric neoplasms. Editorial Board of J Gastric Cancer publishes original articles on pathophysiology, molecular oncology, diagnosis, treatment, and prevention of gastric cancer as well as articles on dietary control and improving the quality of life for gastric cancer patients. J Gastric Cancer includes case reports, review articles, how I do it articles, editorials, and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信